참고문헌
- Scher HI, Halabi S, Tannock I, Morris M, Sternberg CN, Carducci MA, et al. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol 2008;26:1148-59. https://doi.org/10.1200/JCO.2007.12.4487
- Basu S, Alavi A. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades. J Nucl Med 2008;49:17N-21N, 37N.
- Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002;2:683-93. https://doi.org/10.1038/nrc882
- Phelps ME. PET: the merging of biology and imaging into molecular imaging. J Nucl Med 2000;41:661-81.
- Jadvar H. FDG PET in Prostate Cancer. PET clinics 2009;4:155-61. https://doi.org/10.1016/j.cpet.2009.05.002
- Lebret T, Mejean A. [Rare locations of metastases from prostate cancer]. Pro Urol 2008;18:S357-64. https://doi.org/10.1016/S1166-7087(08)74567-6
- Venara A, Thibaudeau E, Lebdai S, Mucci S, Ridereau-Zins C, Azzouzi R, et al. Rectal metastasis of prostate cancer: about a case. J Clin med res 2010;2:137-9.
- Bowrey DJ, Otter MI, Billings PJ. Rectal infiltration by prostatic adenocarcinoma: report on six patients and review of the literature. Ann R Coll Surg Engl 2003;85:382-5. https://doi.org/10.1308/003588403322520726
- Liu L, Devine P, Einhorn E, Kao GD. Incidental finding of an isolated prostate cancer metastasis in an inguinal hernial sac. J Urol 2000;164:457-8. https://doi.org/10.1016/S0022-5347(05)67392-2
- Kanamaru H, Oyama N, Akino H, Okada K. [Evaluation of prostate cancer using FDG-PET]. Hinyokika kiyo. 2000;46:851-3.
- Liu IJ, Zafar MB, Lai YH, Segall GM, Terris MK. Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology 2001;57:108-11. https://doi.org/10.1016/S0090-4295(00)00896-7
- Jadvar H, Pinski JK, Conti PS. FDG PET in suspected recurrent and metastatic prostate cancer. Oncology reports 2003;10:1485-8.
- Agus DB, Golde DW, Sgouros G, Ballangrud A, Cordon-Cardo C, Scher HI. Positron emission tomography of a human prostate cancer xenograft: association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal. Cancer Res 1998;58:3009-14.
- Oyama N, Akino H, Suzuki Y, Kanamaru H, Sadato N, Yonekura Y, et al. The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer. Jpn J Oncol 1999;29:623-9. https://doi.org/10.1093/jjco/29.12.623
- Sanz G, Robles JE, Gimenez M, Arocena J, Sanchez D, Rodriguez-Rubio F, et al. Positron emission tomography with 18fluorine-labelled deoxyglucose: utility in localized and advanced prostate cancer. BJU Int 1999;84:1028-31.